ExpreS2ion Biotech Holding AB (publ) (STO: EXPRS2)

STO: EXPRS2 Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	53	108	622	1,145	301	53
Market Cap Growth	15.32%	-82.55%	-45.72%	280.55%	470.21%	-30.86%
Enterprise Value	-22	33	474	1,005	282	51
Last Close Price	25.00	84.40	661.20	1433.65	425.10	151.32
PS Ratio	4.59	12.33	101.08	83.41	19.72	3.82
PB Ratio	0.76	1.66	6.02	8.16	3.18	-48.91
P/TBV Ratio	1.23	1.72	6.19	8.35	3.33	-
EV/Sales Ratio	2.06	3.79	77.06	73.21	18.45	3.69
Debt / Equity Ratio	0.03	0.03	0.02	0.02	0.03	-2.31
Asset Turnover	-	0.08	0.04	0.10	0.22	0.70
Quick Ratio	2.83	5.99	3.87	19.57	6.15	0.80
Current Ratio	2.85	6.03	4.20	19.63	6.18	0.83
Return on Equity (ROE)	-	-108.36%	-97.35%	-37.40%	-67.86%	-477.90%
Return on Assets (ROA)	-	-61.31%	-55.13%	-19.06%	-28.35%	-53.10%
Return on Capital (ROIC)	-	-76.90%	-64.41%	-21.56%	-39.65%	-198.00%
Earnings Yield	-93.32%	-84.27%	-19.08%	-3.84%	-10.54%	-32.70%
FCF Yield	-84.36%	-94.87%	-16.09%	-4.05%	-6.33%	-21.79%
Buyback Yield / Dilution	-36.62%	-31.49%	-20.02%	-68.61%	-31.37%	-14.39%
Total Shareholder Return	-36.62%	-31.49%	-20.02%	-68.61%	-31.37%	-14.39%

Source: S&P Capital IQ. Standard template. Financial Sources.